Human data validate Cambrian Bio’s aging target (opens in new tab)

Positive Phase 1b results for ATX-304 suggest scientists may finally be able to restore a key metabolic pathway that declines with age. There are few ideas in aging biology that have generated as much excitement (and as much disappointment) as AMPK. Researchers have viewed this cellular pathway as one of the body’s most important regulators […] The post appeared first on <a href="